Market Place
Sourcing Support
BioSyent Schedules Q3 & YTD 2024 Earnings Release Nov 20
13 Nov 2024 //
GLOBENEWSWIRE
BioSyent To Purchase Tibelia Assets
20 Sep 2024 //
GLOBENEWSWIRE
BioSyent Declares Third Quarter 2024 Dividend
26 Aug 2024 //
GLOBENEWSWIRE
BioSyent Releases Financial Results for Q2 and H1 2024
26 Aug 2024 //
GLOBENEWSWIRE
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024
09 May 2024 //
GLOBENEWSWIRE
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
10 Apr 2024 //
GLOBENEWSWIRE
BioSyent to Present at LD Micro New York Investor Conference
01 Apr 2024 //
GLOBENEWSWIRE
BioSyent Announces Renewal of Normal Course Issuer Bid
13 Dec 2023 //
GLOBENEWSWIRE
BioSyent Declares Fourth Quarter 2023 Dividend
15 Nov 2023 //
GLOBENEWSWIRE
BioSyent Launches menopauseinformation.ca" on World Menopause Day"""
18 Oct 2023 //
GLOBENEWSWIRE
BioSyent Schedules Q2 and H1 2023 Earnings Release for August 22, 2023
15 Aug 2023 //
GLOBENEWSWIRE
BioSyent Launches Inofolic® for Women with Polycystic Ovary Syndrome (PCOS)
08 Aug 2023 //
GLOBENEWSWIRE
BioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference
06 Jul 2023 //
GLOBENEWSWIRE
BioSyent Announces Approval of New Product
31 May 2023 //
GLOBENEWSWIRE
BioSyent Releases Financial Results for Q1 2023
26 May 2023 //
GLOBENEWSWIRE
BioSyent Declares Second Quarter 2023 Dividend
25 May 2023 //
GLOBENEWSWIRE
BioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
18 May 2023 //
GLOBENEWSWIRE
BioSyent Announces Grant of Restricted Share Units
31 Mar 2023 //
GLOBENEWSWIRE
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2022
21 Mar 2023 //
GLOBENEWSWIRE
BioSyent Schedules Q4 and Full Year 2022 Earnings Release for March 21, 2023
09 Mar 2023 //
GLOBENEWSWIRE
BioSyent Announces Launch of New FeraMAX Pd Maintenance 45
07 Mar 2023 //
GLOBENEWSWIRE
BioSyent Declares First Quarter 2023 Dividend
01 Feb 2023 //
GLOBENEWSWIRE
BioSyent Signs Exclusive Agreement for Oncology Supportive Care Product
14 Dec 2022 //
GLOBENEWSWIRE
BioSyent Announces Renewal of Normal Course Issuer Bid
13 Dec 2022 //
GLOBENEWSWIRE
BioSyent Initiates First Dividend
12 Oct 2022 //
GLOBENEWSWIRE
BioSyent Releases Q2 and H1 2022 Financial Results
23 Aug 2022 //
GLOBENEWSWIRE
BioSyent Announces Adoption of Dividend Policy
23 Aug 2022 //
GLOBENEWSWIRE
BioSyent Schedules Q2 and H1 2022 Earnings Release for August 23, 2022
16 Aug 2022 //
GLOBENEWSWIRE
BioSyent Releases Financial Results for Q1 2022
18 May 2022 //
GLOBENEWSWIRE
BioSyent Schedules Q1 2022 Earnings Release for May 18, 2022
10 May 2022 //
GLOBENEWSWIRE
Investor
26 Apr 2022 //
GLOBENEWSWIRE
BioSyent Announces Grant of Restricted Share Units
31 Mar 2022 //
GLOBENEWSWIRE
BioSyent Releases Financial Results for Q4 and FY 2021
09 Mar 2022 //
GLOBENEWSWIRE
BioSyent Schedules Q4 and Full Year 2021 Earnings Release for March 9, 2022
03 Mar 2022 //
GLOBENEWSWIRE
BioSyent Announces Launch of New FeraMAX® Pd Powder 15
19 Oct 2021 //
BIOSPACE
BioSyent Releases Q2 and H1 2021 Financial Results
25 Aug 2021 //
GLOBENEWSWIRE
Photocure Regains Rights to Cysview in Canada
25 Aug 2021 //
PRNEWSWIRE
BioSyent Schedules Q2 and H1 2021 Earnings Release for August 25, 2021
17 Aug 2021 //
GLOBENEWSWIRE
BioSyent Signs Exclusive Technology Agreement
13 Jul 2021 //
GLOBENEWSWIRE
BioSyent Signs Exclusive Agreement for Pain Management Products
26 Nov 2019 //
GLOBE NEWSWIRE
